Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Arthritis Care & Research
|
February 12, 2019
Timing of Abatacept Before Elective Arthroplasty and Risk of Postoperative Outcomes
Michael D George, Joshua F Baker, Kevin Winthrop, et al.
Annals of Internal Medicine
|
May 21, 2019
Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study
Michael D George, Joshua F Baker, Kevin Winthrop, et al.
RMD Open
|
February 27, 2020
Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis
Masayoshi Harigai, Kevin Winthrop, Tsutomu Takeuchi, et al.
Mbio
|
May 21, 2024
Immunological and microbial shifts in the aging rhesus macaque lung during nontuberculous mycobacterial infection
Isaac R Cinco, Ethan G Napier, Nicholas S Rhoades, et al.
Emerging Infectious Diseases
|
June 5, 2003
Leptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000
James Sejvar, Elizabeth Bancroft, Kevin Winthrop, et al.
Rheumatology and Therapy
|
December 31, 2021
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Gerd R Burmester, Kevin Winthrop, Ricardo Blanco, et al.
Research Square
|
February 13, 2026
Lung microbial dysregulation and TNF inhibition contribute to worsened nontuberculous mycobacterial lung disease
Ethan Napier, Isaac Cinco, Ethan Stuart, et al.
American Journal of Clinical Dermatology
|
June 18, 2024
Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure
Eric L Simpson, Jonathan I Silverberg, Audrey Nosbaum, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 12, 2022
A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus
Kenneth C Kalunian, Richard Furie, Eric F Morand, et al.
Annals of the Rheumatic Diseases
|
February 11, 2025
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statement
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Arthritis Care & Research
|
February 12, 2019
Timing of Abatacept Before Elective Arthroplasty and Risk of Postoperative Outcomes
Michael D George, Joshua F Baker, Kevin Winthrop, et al.
Annals of Internal Medicine
|
May 21, 2019
Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study
Michael D George, Joshua F Baker, Kevin Winthrop, et al.
RMD Open
|
February 27, 2020
Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis
Masayoshi Harigai, Kevin Winthrop, Tsutomu Takeuchi, et al.
Mbio
|
May 21, 2024
Immunological and microbial shifts in the aging rhesus macaque lung during nontuberculous mycobacterial infection
Isaac R Cinco, Ethan G Napier, Nicholas S Rhoades, et al.
Emerging Infectious Diseases
|
June 5, 2003
Leptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000
James Sejvar, Elizabeth Bancroft, Kevin Winthrop, et al.
Rheumatology and Therapy
|
December 31, 2021
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Gerd R Burmester, Kevin Winthrop, Ricardo Blanco, et al.
Research Square
|
February 13, 2026
Lung microbial dysregulation and TNF inhibition contribute to worsened nontuberculous mycobacterial lung disease
Ethan Napier, Isaac Cinco, Ethan Stuart, et al.
American Journal of Clinical Dermatology
|
June 18, 2024
Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure
Eric L Simpson, Jonathan I Silverberg, Audrey Nosbaum, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 12, 2022
A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus
Kenneth C Kalunian, Richard Furie, Eric F Morand, et al.
Annals of the Rheumatic Diseases
|
February 11, 2025
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statement
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Page
of 8